Our Research Publications
Updated June 2019
Pagination
- Previous page
- Page 2
- Next page
Title | Authors | Year Sort ascending | Journal | Link to Article | Intended Audience | Purpose |
---|---|---|---|---|---|---|
Addressing the identity crisis in healthcare: positive patient identification technology reduces wrong patient events | Callum J, Etchells E, Shojania K | 2019 | Transfusion | View Addressing the identity crisis in healthcare: positive patient identification technology reduces wrong patient events | Health care providers | Clinical research |
Safety of blood donation by individuals over age 70 and their contribution to the blood supply in five developed countries: a BEST Collaborative group study | Goldman M, Germain M, Gregoire Y, Vassallo RR, Kamel H, Bravo M, Irving DO, Di Angelantonio E, Steele WR, O'Brien SF, for the Biomedical Excellence for Safer Transfusion Collaborative (BEST) Investigators | 2019 | Transfusion | View Safety of blood donation by individuals over age 70 and their contribution to the blood supply in five developed countries: a BEST Collaborative group study | Blood operators | New or improved product or process |
The sensitivity and specificity of platelet autoantibody testing in immune thrombocytopenia: a systematic review and meta-analysis of a diagnostic test | Vrbensky JR, Moore JE, Arnold DM, Smith JW, Kelton JG, Nazy I | 2019 | J Thromb Haemost | View The sensitivity and specificity of platelet autoantibody testing in immune thrombocytopenia: a systematic review and meta-analysis of a diagnostic test | Researchers | Clinical research |
Paracrine Factors Released by Osteoblasts Provide Strong Platelet Engraftment Properties | Abu-Khader A, Law KW, Jahan S, Manesia JK, Pasha R, Hovey O, Pineault N | 2019 | Stem Cells | View Paracrine Factors Released by Osteoblasts Provide Strong Platelet Engraftment Properties | Researchers | Basic research |
Genomic data in prognostic models-what is lost in translation? The case of deletion 17p and mutant TP53 in chronic lymphocytic leukaemia | Chin-Yee B, Sadikovic B, Chin-Yee I | 2019 | Br J Haematol | View Genomic data in prognostic models-what is lost in translation? The case of deletion 17p and mutant TP53 in chronic lymphocytic leukaemia | Researchers | Clinical research |
Reducing red blood cell folate testing: a case study in utilisation management | Ismail O, Chin-Yee I, Gob A, Bhayana V, Rutledge A | 2019 | BMJ Open Quality | View Reducing red blood cell folate testing: a case study in utilisation management | Researchers | Basic research |
Translating red cell “omics” into new perspectives in transfusion medicine: mining the gems in the data mountains | Spitalnik SL, Devine DV | 2019 | Transfusion | View Translating red cell “omics” into new perspectives in transfusion medicine: mining the gems in the data mountains | Researchers | Other |
Fetal and Neonatal Alloimmune Thrombocytopenia: Patient Information | International Collaboration for Transfusion Medicine Guidelines | 2019 | ICTMG.org website | View Fetal and Neonatal Alloimmune Thrombocytopenia: Patient Information | Other | Other |
ResearchUnit: One in a million: Modelling rare blood flow | Blake J, Clarke G | 2019 | Blood.ca website | View ResearchUnit: One in a million: Modelling rare blood flow | Researchers | Clinical research |
A platelet viability assay (PVA) for the diagnosis of heparin-induced thrombocytopenia | Ivetic N, Arnold D, Smith J, Huynh A, Kelton J, Nazy I | 2019 | Platelets | View A platelet viability assay (PVA) for the diagnosis of heparin-induced thrombocytopenia | Researchers | Basic research |
Impact of Adopting Population Pharmacokinetics for Tailoring Prophylaxis in Haemophilia A Patients: A Historically Controlled Observational Study | Stemberger M, Kallenbach F, Schmit E, McEneny-King A, Germini F, Yeung CHT, Edginton AN, von Mackensen S, Kurnik K, Iorio A | 2019 | Thromb Haemost | View Impact of Adopting Population Pharmacokinetics for Tailoring Prophylaxis in Haemophilia A Patients: A Historically Controlled Observational Study | Health care providers | Clinical research |
Safeguarding the Patient's Own Blood Supply | Zeller MP, Kaufman RM | 2019 | JAMA | View Safeguarding the Patient's Own Blood Supply | Health care providers | Clinical research |
Blood and clots series: Which antithrombotic therapy should I start for my patient with acute VTE? | Tseng E | 2018 | CanadiEM website | View Blood and clots series: Which antithrombotic therapy should I start for my patient with acute VTE? | Health care providers | Benchmarking and standard setting |
Rivaroxaban and Apixaban induce clotting factor Xa fibrinolytic activity | Carter RLR, Talbot K, Hur WS, Meixner SC, Van Der Gugten JG, Holmes DT, Côté HCF, Kastrup CJ, Smith TW, Lee AYY, Pryzdial ELG | 2018 | J Thromb Haemost | View Rivaroxaban and Apixaban induce clotting factor Xa fibrinolytic activity | Health care providers | Basic research |
Moving from a permanent to a 5 year deferral for donors with cured cancer results in a substantial reduction in deferral rates | Goldman M, Yi Q-L, O'Brien SF | 2018 | ISBT Sci Ser | View Moving from a permanent to a 5 year deferral for donors with cured cancer results in a substantial reduction in deferral rates | Blood operators | New or improved product or process |
Improving quality of care for patients with iron deficiency anemia presenting to the emergency department | Khadadah F, Callum J, Shelton D, Lin Y | 2018 | Transfusion | View Improving quality of care for patients with iron deficiency anemia presenting to the emergency department | Health care providers | Clinical research |
Surveillance Report 2017 | O'Brien S | 2018 | Blood.ca website | View Surveillance Report 2017 | Other | Other |
Red blood cells, still vital after all these years: Commentary on Canadian Blood Services' International Symposium 2017 | Qadri SM, Donkor DA, Yan M, Ning S, Branch DR, Seghatchian J, Sheffield WP | 2018 | Transfus Apher Sci | View Red blood cells, still vital after all these years: Commentary on Canadian Blood Services' International Symposium 2017 | Researchers | Other |
Role of von Willebrand factor and ADAMTS-13 in early brain injury after experimental subarachnoid hemorrhage | Wan H, Wang Y, Ai J, Brathwaite S, Ni H, Macdonald RL, Hol EM, Meijers JCM, Vergouwen MDI | 2018 | J Thromb Haemost | View Role of von Willebrand factor and ADAMTS-13 in early brain injury after experimental subarachnoid hemorrhage | Researchers | Basic research |
Exploring donor and product factors and their impact on red cell post-transfusion outcomes | Ning S, Heddle NM, Acker JP | 2018 | Transfus Med Rev | View Exploring donor and product factors and their impact on red cell post-transfusion outcomes | Health care providers | Clinical research |
Platelet-activating antibodies are detectable at the earliest onset of heparin-induced thrombocytopenia, with implications for the operating characteristics of the serotonin-release assay | Warkentin TE, Arnold DM, Kelton JG, Sheppard JI, Smith JW, Nazy I | 2018 | Chest | View Platelet-activating antibodies are detectable at the earliest onset of heparin-induced thrombocytopenia, with implications for the operating characteristics of the serotonin-release assay | Researchers | Clinical research |
Concentré de recherche : Une façon nouvelle d’évaluer la qualité des globules rouges | Acker J | 2018 | Blood.ca website | View Concentré de recherche : Une façon nouvelle d’évaluer la qualité des globules rouges | Researchers | Clinical research |
Anti-M (French) | Clarke G, Côté J, Lane D | 2018 | Blood.ca website | View Anti-M (French) | Researchers | Basic research |
What Goes Up, Must Go Down? | Parker MJ | 2018 | Pediatr Crit Care Med | View What Goes Up, Must Go Down? | Researchers | Clinical research |
Extending the pre-processing holding time of whole blood beyond 48?h reduces coagulation FVIII activity and immunoglobulin G content of recovered plasma | Sheffield WP, Bhakta V, Jenkins C | 2018 | Transfus Apher Sci | View Extending the pre-processing holding time of whole blood beyond 48?h reduces coagulation FVIII activity and immunoglobulin G content of recovered plasma | Researchers | New or improved product or process |
Approaches for analysis of erythroid cell parameters and hemoglobinopathies in mouse models | Trudel M, Sedzro JC | 2018 | Methods Mol Biol | View Approaches for analysis of erythroid cell parameters and hemoglobinopathies in mouse models | Researchers | Basic research |
A Deep Learning Method to Automatically Identify Reports of Scientifically Rigorous Clinical Research from the Biomedical Literature: Comparative Analytic Study | Del Fiol G MM, Iorio A, Cotoi C, Haynes RB | 2018 | J Med Internet Res | View A Deep Learning Method to Automatically Identify Reports of Scientifically Rigorous Clinical Research from the Biomedical Literature: Comparative Analytic Study | Researchers | Clinical research |
Circular of information for the use of human blood components: Red blood cells, Leukocytes Reduced (LR) | Jenkins C | 2018 | Blood.ca website | View Circular of information for the use of human blood components: Red blood cells, Leukocytes Reduced (LR) | Health care providers | Benchmarking and standard setting |
Sample collection and sample handling errors submitted to the transfusion error surveillance system, 2006 to 2015 | Strauss R, Downie H, Wilson A, Mounchili A, Berry B, Cserti-Gazdewich C, Callum J | 2018 | Transfusion | View Sample collection and sample handling errors submitted to the transfusion error surveillance system, 2006 to 2015 | Health care providers | Clinical research |
Pathogen reduction technologies: The pros and cons for platelet transfusion | Magron A, Laugier J, Provost P, Boilard E | 2018 | Platelets | View Pathogen reduction technologies: The pros and cons for platelet transfusion | Blood operators | Basic research |
Psychometric properties of the Patient Reported Outcomes, Burdens and Experiences (PROBE) questionnaire | Chai-Adisaksopha C, Skinner MW, Curtis R, Frick N, Nichol MB, Noone D, O’Mahony B, Page D, Stonebraker J, Thabane L, Crowther M, Iorio A | 2018 | BMJ Open | View Psychometric properties of the Patient Reported Outcomes, Burdens and Experiences (PROBE) questionnaire | Researchers | Clinical research |
Performance of Stool-testing Recommendations for Acute Gastroenteritis When Used to Identify Children With 9 Potential Bacterial Enteropathogens | Kim K, Tarr GAM, Chui L, Drews S, Pang X-L, Lee BE, Ali S, Nettel-Aguirre A, Vanderkooi OG, Berenger BM, Dickinson J, Tarr PI, MacDonald J, Freedman SB | 2018 | Clin Infect Dis | View Performance of Stool-testing Recommendations for Acute Gastroenteritis When Used to Identify Children With 9 Potential Bacterial Enteropathogens | Health care providers | Clinical research |
Rapport de surveillance 2017 | O'Brien S | 2018 | Blood.ca website | View Rapport de surveillance 2017 | Other | Other |
Bacterial neuraminidase-mediated erythrocyte desialylation provokes cell surface aminophospholipid exposure | Qadri SM, Donkor DA, Nazy I, Branch DR, Sheffield WP | 2018 | Eur J Haematol | View Bacterial neuraminidase-mediated erythrocyte desialylation provokes cell surface aminophospholipid exposure | Researchers | Basic research |
Chloride and other electrolyte concentrations in commonly available 5% albumin products | Lai AT, Zeller MP, Millen T, Kavsak P, Szczeklik W, Elahie A, Alhazzani W, D'Aragon F, Jaeschke R, Lamontagne F, Karachi T, Cook D, Meade M, Rochwerg B | 2018 | Crit Care Med | View Chloride and other electrolyte concentrations in commonly available 5% albumin products | Researchers | Clinical research |
ResearchUnit: Improving the usefulness of a laboratory tool to match donors and patients | Acker J, Branch D | 2018 | Blood.ca website | View ResearchUnit: Improving the usefulness of a laboratory tool to match donors and patients | Other | Other |
La maladie hémolytique du fœtus et du nouveau-né et thrombopénie immune périnatale | Clarke G, Hannon J | 2018 | Guide de la pratique transfusionnelle | View La maladie hémolytique du fœtus et du nouveau-né et thrombopénie immune périnatale | Health care providers | Other |
The first case of severe acute hemolytic transfusion reaction caused by anti-Sc2 | Lemay A-S, Tong TN, Branch DR, Huang M, Sumner C, Oldfield L, Hawes J, Cserti-Gazdewich CM, Lau W | 2018 | Transfusion | View The first case of severe acute hemolytic transfusion reaction caused by anti-Sc2 | Researchers | Clinical research |
A factor XIa-activatable hirudin-albumin fusion protein reduces thrombosis in mice without promoting blood loss | Sheffield WP, Eltringham-Smith LJ, Bhakta V | 2018 | BMC Biotechnol | View A factor XIa-activatable hirudin-albumin fusion protein reduces thrombosis in mice without promoting blood loss | Researchers | Basic research |
Plerixafor effectively mobilizes CD56bright NK cells in blood, providing an allograft predicted to protect against GVHD | Wong PPC, Kariminia A, Jones D, Eaves CJ, Foley R, Ivison S, Couban S, Schultz KR | 2018 | Blood | View Plerixafor effectively mobilizes CD56bright NK cells in blood, providing an allograft predicted to protect against GVHD | Health care providers | Clinical research |
Long-term graft function following autologous hematopoietic cell transplantation and the impact of preemptive plerixafor in predicted poor mobilizers | Visram A, Bredeson C, Allan D, Sabloff M, Huebsch L, Tay J, Kekre N, McDiarmid S, Mallick R, Tinmouth A, Martin L, Hamelin L, Maze D | 2018 | Blood Cancer J | View Long-term graft function following autologous hematopoietic cell transplantation and the impact of preemptive plerixafor in predicted poor mobilizers | Health care providers | Clinical research |
Modeling rare blood in Canada | Blake JT, Clarke G | 2018 | Transfusion | View Modeling rare blood in Canada | Health care providers | New or improved product or process |
Pathogen inactivation strategies to improve blood safety: Let’s not throw pathogen-reduced platelets out with their bath water | Devine DV | 2018 | JAMA Oncol | View Pathogen inactivation strategies to improve blood safety: Let’s not throw pathogen-reduced platelets out with their bath water | Researchers | New or improved product or process |
Circular of information for the use of human blood components: Platelets | Jenkins C | 2018 | Blood.ca website | View Circular of information for the use of human blood components: Platelets | Health care providers | Benchmarking and standard setting |
Red blood cell antibody-induced anemia causes differential degrees of tissue hypoxia in kidney and brain | Mistry N, Mazer CD, Sled JG, Lazarus AH, Cahill LS, Solish M, Zhou Y-Q, Romanova N, Hare AGM, Doctor A, Fisher JA, Brunt KR, Simpson JA, Hare GMT | 2018 | Am J Physiol Regul Integr Comp Physiol | View Red blood cell antibody-induced anemia causes differential degrees of tissue hypoxia in kidney and brain | Researchers | Basic research |
Autoantibodies to thrombopoietin and the thrombopoietin receptor in patients with immune thrombocytopenia | Nazy I, Kelton JG, Moore JC, Clare R, Horsewood P, Smith JW, Ivetic N, D'Souza V, Li N, Arnold DM | 2018 | Br J Haematol | View Autoantibodies to thrombopoietin and the thrombopoietin receptor in patients with immune thrombocytopenia | Health care providers | Clinical research |
Changes in plasma unit distributions to hospitals over a 10-year period | Seheult JN, Shaz B, Bravo M, Croxon H, Devine D, Doncaster C, Field S, Flanagan P, Germain M, Gregoire Y, Kamel H, Karafin M, Kelting N, Lewis M, O'Brien C, Murphy MF, Rossmann S, Sayers M, Shinar E, Takanashi M, Titlestad K, Yazer MH | 2018 | Transfusion | View Changes in plasma unit distributions to hospitals over a 10-year period | Blood operators | Clinical research |
Does my complex patient have DIC? | Shih A | 2018 | CanadiEM website | View Does my complex patient have DIC? | Health care providers | Other |
Fetal and neonatal alloimmune thrombocytopenia: Novel mechanisms of miscarriage learned from placental pathology in animal models | Yougbaré I, Zdravic D, Ni H | 2018 | J Pediatr Pediatr Med | View Fetal and neonatal alloimmune thrombocytopenia: Novel mechanisms of miscarriage learned from placental pathology in animal models | Researchers | Basic research |
Questioning some recommendations in the umbilical cord blood guideline | Elmoazzen H, Petraszko T | 2018 | J Obstet Gynaecol Can | View Questioning some recommendations in the umbilical cord blood guideline | Health care providers | New or improved product or process |